Global Regenerative Medicine Market Insights, Forecast to 2029

Publisher Name :
Date: 20-Sep-2023
No. of pages: 125
Inquire Before Buying

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body's innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and "the vanguard of 21st century healthcare" by the U.S. Department of Health and Human Services.

Market Analysis and Insights: Global Regenerative Medicine Market

The global Regenerative Medicine market is projected to grow from US$ 40320 million in 2023 to US$ 115660 million by 2029, at a Compound Annual Growth Rate (CAGR) of 19.2% during the forecast period.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

Report Includes

This report presents an overview of global market for Regenerative Medicine market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Regenerative Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Regenerative Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Regenerative Medicine revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Regenerative Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Regenerative Medicine revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics and Osiris Therapeutics, etc.

By Company

- J & J (DePuy Synthes)

- Medtronic

- Zimmer Biomet

- Stryker

- Allergan(Acelity)

- MiMedx Group

- Organogenesis

- Fujifilm Cellular Dynamics

- Osiris Therapeutics

- Vcanbio

- CCBC

- Cytori

- Celgene

- Vericel Corporation

- Guanhao Biotech

- Mesoblast

- AMAG Pharmaceuticals (CBR)

- ViaCord

- CordLife

- Integra LifeSciences

- Nuvasive

- Cook Biotech

- Japan Tissue Engineering

Segment by Type

- Cell Therapy

- Tissue Engineering

- Biomaterial

- Other

Segment by Application

- Dermatology

- Cardiovascular

- CNS

- Orthopedic

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Regenerative Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Regenerative Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regenerative Medicine revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Regenerative Medicine Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2018-2029)
2.2 Global Regenerative Medicine Growth Trends by Region
2.2.1 Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Regenerative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2024-2029)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Regenerative Medicine by Players
3.1.1 Global Regenerative Medicine Revenue by Players (2018-2023)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Regenerative Medicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2022
3.5 Global Key Players of Regenerative Medicine Head office and Area Served
3.6 Global Key Players of Regenerative Medicine, Product and Application
3.7 Global Key Players of Regenerative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2024-2029)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Regenerative Medicine Market Size (2018-2029)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2018-2023)
6.2.2 North America Regenerative Medicine Market Size by Type (2024-2029)
6.2.3 North America Regenerative Medicine Market Share by Type (2018-2029)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 North America Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 North America Regenerative Medicine Market Share by Application (2018-2029)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Regenerative Medicine Market Size by Country (2018-2023)
6.4.3 North America Regenerative Medicine Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2018-2029)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2018-2023)
7.2.2 Europe Regenerative Medicine Market Size by Type (2024-2029)
7.2.3 Europe Regenerative Medicine Market Share by Type (2018-2029)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2018-2023)
7.3.2 Europe Regenerative Medicine Market Size by Application (2024-2029)
7.3.3 Europe Regenerative Medicine Market Share by Application (2018-2029)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Regenerative Medicine Market Size by Country (2018-2023)
7.4.3 Europe Regenerative Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Regenerative Medicine Market Size (2018-2029)
8.2 China Regenerative Medicine Market Size by Type
8.2.1 China Regenerative Medicine Market Size by Type (2018-2023)
8.2.2 China Regenerative Medicine Market Size by Type (2024-2029)
8.2.3 China Regenerative Medicine Market Share by Type (2018-2029)
8.3 China Regenerative Medicine Market Size by Application
8.3.1 China Regenerative Medicine Market Size by Application (2018-2023)
8.3.2 China Regenerative Medicine Market Size by Application (2024-2029)
8.3.3 China Regenerative Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Regenerative Medicine Market Size (2018-2029)
9.2 Asia Regenerative Medicine Market Size by Type
9.2.1 Asia Regenerative Medicine Market Size by Type (2018-2023)
9.2.2 Asia Regenerative Medicine Market Size by Type (2024-2029)
9.2.3 Asia Regenerative Medicine Market Share by Type (2018-2029)
9.3 Asia Regenerative Medicine Market Size by Application
9.3.1 Asia Regenerative Medicine Market Size by Application (2018-2023)
9.3.2 Asia Regenerative Medicine Market Size by Application (2024-2029)
9.3.3 Asia Regenerative Medicine Market Share by Application (2018-2029)
9.4 Asia Regenerative Medicine Market Size by Region
9.4.1 Asia Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Regenerative Medicine Market Size by Region (2018-2023)
9.4.3 Asia Regenerative Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Regenerative Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Regenerative Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023)
11.1.5 J & J (DePuy Synthes) Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2018-2023)
11.2.5 Medtronic Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023)
11.3.5 Zimmer Biomet Recent Developments
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2018-2023)
11.4.5 Stryker Recent Developments
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Details
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023)
11.5.5 Allergan(Acelity) Recent Developments
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2018-2023)
11.6.5 MiMedx Group Recent Developments
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2018-2023)
11.7.5 Organogenesis Recent Developments
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023)
11.8.5 Fujifilm Cellular Dynamics Recent Developments
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023)
11.9.5 Osiris Therapeutics Recent Developments
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2018-2023)
11.10.5 Vcanbio Recent Developments
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2018-2023)
11.11.5 CCBC Recent Developments
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2018-2023)
11.12.5 Cytori Recent Developments
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2018-2023)
11.13.5 Celgene Recent Developments
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023)
11.14.5 Vericel Corporation Recent Developments
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023)
11.15.5 Guanhao Biotech Recent Developments
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2018-2023)
11.16.5 Mesoblast Recent Developments
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Developments
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2018-2023)
11.18.5 ViaCord Recent Developments
11.19 CordLife
11.19.1 CordLife Company Details
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2018-2023)
11.19.5 CordLife Recent Developments
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023)
11.20.5 Integra LifeSciences Recent Developments
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2018-2023)
11.21.5 Nuvasive Recent Developments
11.22 Cook Biotech
11.22.1 Cook Biotech Company Details
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2018-2023)
11.22.5 Cook Biotech Recent Developments
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023)
11.23.5 Japan Tissue Engineering Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Region (2018-2023)
Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Region (2024-2029)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Regenerative Medicine Revenue Share by Players (2018-2023)
Table 18. Global Top Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
Table 19. Global Regenerative Medicine Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Regenerative Medicine, Headquarters and Area Served
Table 22. Global Key Players of Regenerative Medicine, Product and Application
Table 23. Global Key Players of Regenerative Medicine, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2024-2029)
Table 29. Global Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Share by Application (2018-2023)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Regenerative Medicine Revenue Share by Application (2024-2029)
Table 33. North America Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Regenerative Medicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Regenerative Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 65. J & J (DePuy Synthes) Company Details
Table 66. J & J (DePuy Synthes) Business Overview
Table 67. J & J (DePuy Synthes) Regenerative Medicine Product
Table 68. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 69. J & J (DePuy Synthes) Recent Developments
Table 70. Medtronic Company Details
Table 71. Medtronic Business Overview
Table 72. Medtronic Regenerative Medicine Product
Table 73. Medtronic Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 74. Medtronic Recent Developments
Table 75. Zimmer Biomet Company Details
Table 76. Zimmer Biomet Business Overview
Table 77. Zimmer Biomet Regenerative Medicine Product
Table 78. Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 79. Zimmer Biomet Recent Developments
Table 80. Stryker Company Details
Table 81. Stryker Business Overview
Table 82. Stryker Regenerative Medicine Product
Table 83. Stryker Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 84. Stryker Recent Developments
Table 85. Allergan(Acelity) Company Details
Table 86. Allergan(Acelity) Business Overview
Table 87. Allergan(Acelity) Regenerative Medicine Product
Table 88. Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 89. Allergan(Acelity) Recent Developments
Table 90. MiMedx Group Company Details
Table 91. MiMedx Group Business Overview
Table 92. MiMedx Group Regenerative Medicine Product
Table 93. MiMedx Group Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 94. MiMedx Group Recent Developments
Table 95. Organogenesis Company Details
Table 96. Organogenesis Business Overview
Table 97. Organogenesis Regenerative Medicine Product
Table 98. Organogenesis Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 99. Organogenesis Recent Developments
Table 100. Fujifilm Cellular Dynamics Company Details
Table 101. Fujifilm Cellular Dynamics Business Overview
Table 102. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 103. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 104. Fujifilm Cellular Dynamics Recent Developments
Table 105. Osiris Therapeutics Company Details
Table 106. Osiris Therapeutics Business Overview
Table 107. Osiris Therapeutics Regenerative Medicine Product
Table 108. Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 109. Osiris Therapeutics Recent Developments
Table 110. Vcanbio Company Details
Table 111. Vcanbio Business Overview
Table 112. Vcanbio Regenerative Medicine Product
Table 113. Vcanbio Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 114. Vcanbio Recent Developments
Table 115. CCBC Company Details
Table 116. CCBC Business Overview
Table 117. CCBC Regenerative Medicine Product
Table 118. CCBC Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 119. CCBC Recent Developments
Table 120. Cytori Company Details
Table 121. Cytori Business Overview
Table 122. Cytori Regenerative Medicine Product
Table 123. Cytori Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 124. Cytori Recent Developments
Table 125. Celgene Company Details
Table 126. Celgene Business Overview
Table 127. Celgene Regenerative Medicine Product
Table 128. Celgene Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 129. Celgene Recent Developments
Table 130. Vericel Corporation Company Details
Table 131. Vericel Corporation Business Overview
Table 132. Vericel Corporation Regenerative Medicine Product
Table 133. Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 134. Vericel Corporation Recent Developments
Table 135. Guanhao Biotech Company Details
Table 136. Guanhao Biotech Business Overview
Table 137. Guanhao Biotech Regenerative Medicine Product
Table 138. Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 139. Guanhao Biotech Recent Developments
Table 140. Mesoblast Company Details
Table 141. Mesoblast Business Overview
Table 142. Mesoblast Regenerative Medicine Product
Table 143. Mesoblast Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 144. Mesoblast Recent Developments
Table 145. AMAG Pharmaceuticals (CBR) Company Details
Table 146. AMAG Pharmaceuticals (CBR) Business Overview
Table 147. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 148. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 149. AMAG Pharmaceuticals (CBR) Recent Developments
Table 150. ViaCord Company Details
Table 151. ViaCord Business Overview
Table 152. ViaCord Regenerative Medicine Product
Table 153. ViaCord Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 154. ViaCord Recent Developments
Table 155. CordLife Company Details
Table 156. CordLife Business Overview
Table 157. CordLife Regenerative Medicine Product
Table 158. CordLife Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 159. CordLife Recent Developments
Table 160. Integra LifeSciences Company Details
Table 161. Integra LifeSciences Business Overview
Table 162. Integra LifeSciences Regenerative Medicine Product
Table 163. Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 164. Integra LifeSciences Recent Developments
Table 165. Nuvasive Company Details
Table 166. Nuvasive Business Overview
Table 167. Nuvasive Regenerative Medicine Product
Table 168. Nuvasive Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 169. Nuvasive Recent Developments
Table 170. Cook Biotech Company Details
Table 171. Cook Biotech Business Overview
Table 172. Cook Biotech Regenerative Medicine Product
Table 173. Cook Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 174. Cook Biotech Recent Developments
Table 175. Japan Tissue Engineering Company Details
Table 176. Japan Tissue Engineering Business Overview
Table 177. Japan Tissue Engineering Regenerative Medicine Product
Table 178. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 179. Japan Tissue Engineering Recent Developments
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Regenerative Medicine Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy Features
Figure 4. Tissue Engineering Features
Figure 5. Biomaterial Features
Figure 6. Other Features
Figure 7. Global Regenerative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Regenerative Medicine Market Share by Application: 2022 VS 2029
Figure 9. Dermatology Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. CNS Case Studies
Figure 12. Orthopedic Case Studies
Figure 13. Others Case Studies
Figure 14. Regenerative Medicine Report Years Considered
Figure 15. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Regenerative Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Regenerative Medicine Market Share by Region: 2022 VS 2029
Figure 18. Global Regenerative Medicine Market Share by Players in 2022
Figure 19. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2022
Figure 21. North America Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Regenerative Medicine Market Share by Type (2018-2029)
Figure 23. North America Regenerative Medicine Market Share by Application (2018-2029)
Figure 24. North America Regenerative Medicine Market Share by Country (2018-2029)
Figure 25. United States Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Regenerative Medicine Market Share by Type (2018-2029)
Figure 29. Europe Regenerative Medicine Market Share by Application (2018-2029)
Figure 30. Europe Regenerative Medicine Market Share by Country (2018-2029)
Figure 31. Germany Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Regenerative Medicine Market Share by Type (2018-2029)
Figure 39. China Regenerative Medicine Market Share by Application (2018-2029)
Figure 40. Asia Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Regenerative Medicine Market Share by Type (2018-2029)
Figure 42. Asia Regenerative Medicine Market Share by Application (2018-2029)
Figure 43. Asia Regenerative Medicine Market Share by Region (2018-2029)
Figure 44. Japan Regenerative Medicine Market
  • Global Tissue Engineered Skin Substitutes Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
  • Global Tissue Engineering Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
  • Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150
    According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
  • Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
  • Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
  • Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96
    The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
  • Global Tissue Engineering and Regeneration Market Research Report 2023
    Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......
  • Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Regenerative Medicine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950
    Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs